TY - JOUR AU - Huang, Cheng AU - Zhu, Xiao-Dong AU - Shen, Ying-Hao AU - Wu, Dong AU - Ji, Yuan AU - Ge, Ning-Ling AU - Chen, Ling-Li AU - Tan, Chang-Jun AU - Zhou, Jian AU - Fan, Jia AU - Sun, Hui-Chuan PY - 2021 DA - 2021/03/20 TI - Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis JO - Biomarker Research SP - 19 VL - 9 IS - 1 AB - We evaluated organ-specific response rates (OSRRs) to first-line lenvatinib plus anti-PD-1 antibodies in patients with advanced hepatocellular carcinoma (HCC). SN - 2050-7771 UR - https://doi.org/10.1186/s40364-021-00274-z DO - 10.1186/s40364-021-00274-z ID - Huang2021 ER -